Adverts

Open Access Articles- Top Results for Caplacizumab

Caplacizumab

</th></tr>
Caplacizumab?
Monoclonal antibody
Type Whole antibody
Source Humanized
Target VWF
Clinical data
Identifiers
915810-67-2
None
Chemical data
Formula C1213H1891N357O380S10
27.88 kDa

Caplacizumab (INN) is a monoclonal antibody designed for the treatment of thrombotic thrombocytopenic purpura and thrombosis.[1][2]

This drug was developed by Ablynx NV.

References

  1. ^ Statement On A Nonproprietary Name Adopted By The USAN Council - Caplacizumab, American Medical Association.
  2. ^ World Health Organization (2011). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 106" (PDF). WHO Drug Information 25 (4). 




Lua error in package.lua at line 80: module 'Module:Buffer' not found.